KR860000845B1 - Process for preparing chromore-2-carboxylic acid and salts thereof - Google Patents

Process for preparing chromore-2-carboxylic acid and salts thereof Download PDF

Info

Publication number
KR860000845B1
KR860000845B1 KR1019830000202A KR830000202A KR860000845B1 KR 860000845 B1 KR860000845 B1 KR 860000845B1 KR 1019830000202 A KR1019830000202 A KR 1019830000202A KR 830000202 A KR830000202 A KR 830000202A KR 860000845 B1 KR860000845 B1 KR 860000845B1
Authority
KR
South Korea
Prior art keywords
chromone
carboxylic acid
reacted
acid
diethylamine
Prior art date
Application number
KR1019830000202A
Other languages
Korean (ko)
Other versions
KR840003249A (en
Inventor
쉬브레 앙리
Original Assignee
떼아(떼라뾔띠끄 에 아쁠리까시용) 쏘씨에떼 아노님
쟝 쉬브레
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 떼아(떼라뾔띠끄 에 아쁠리까시용) 쏘씨에떼 아노님, 쟝 쉬브레 filed Critical 떼아(떼라뾔띠끄 에 아쁠리까시용) 쏘씨에떼 아노님
Priority to KR1019830000202A priority Critical patent/KR860000845B1/en
Publication of KR840003249A publication Critical patent/KR840003249A/en
Application granted granted Critical
Publication of KR860000845B1 publication Critical patent/KR860000845B1/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D311/00Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/04Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
    • C07D311/22Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4

Abstract

Chromone-2-carboxylic acids (I) [ R = hydrogen, chloride, methoxy, methyl, hydroxy; M+ = calcium, magnesium cation; B+ = basic cation (diethylamine, morphorine, arginine, lysine) and their derivs. are prepd. for use as a medicine for a vein disease and a capillary vessel disease. Sodiummethylsulfinyl methane, in a mixt. of dimethylsulfoxide and sodium hydride, is reacted with salicylic acid to produce 2'-hydroxy-2-methylsulfinyl acetophenone. Then this compd. is condensed with glyoxylic ethylester to give 2-ethoxycarbonyl-3- methylsulfinyl chromanone derivs. This compd. is hydrolysed to give the tiltle compds.

Description

크로몬-2-카르복실산과 그 염의 제조방법Chromone-2-carboxylic acid and its preparation method

본 발명은 다음의 구조식(I)로 표시되는 크로몬-2-카르복실산이나 크로몬-2-카르복실산치환물 및 그의 유도체를 제조하는 방법에 관한 것으로서,The present invention relates to a method for producing chromone-2-carboxylic acid, chromone-2-carboxylic acid substituent and derivatives thereof represented by the following structural formula (I),

Figure kpo00001
Figure kpo00001

상기 식중 R은 수소나 염소, 메톡시기, 메틸기 또는 하이드록시기를 나타내며, M+는 칼슘이나 마그네슘 같은 양이온, B+는 디에틸아민이나 모르포린 같은 유기염기나 아르기닌이나 리신 같은 염기성아미노산 중에서 선택된 염기성 양이온을 나타낸다.Wherein R represents hydrogen or chlorine, methoxy, methyl or hydroxy group, M + is a cation such as calcium or magnesium, B + is a basic cation selected from organic bases such as diethylamine or morpholine or basic amino acids such as arginine or lysine Indicates.

상기와 같은 구조식(I)로 표시되는 화합물의 유도체에는 칼슘이나 마그네슘 같은 무기염기, 디에틸아민이나 모르포린 같은 유기염기 또는 아르기닌이나 리신같은 염기성아미노산 및 약리학적으로 허용가능한 염기를 첨가시켜서 되어진 염류가 포함된다.Derivatives of the compounds represented by the above formula (I) include salts obtained by adding inorganic bases such as calcium or magnesium, organic bases such as diethylamine or morpholine, basic amino acids such as arginine or lysine, and pharmacologically acceptable bases. Included.

일반적으로 크로몬-2-카르복실산과 특히 그의 디에틸아민염은 정맥질환과 모세혈관질환에 사용되는 혈관보호약제로서 유용한 것으로 알려져 있는바, 종래에 상기 구조식(I)의 화합물을 출발물질로서 0-하이드록시아세토페논과 에틸옥살레이트를 사용하여 제조하였는데, 이와같은 종래의 방법에 따라 제조할 경우 초기 반응물질인 0-하이드록시아세토페논이 최종 생성물이 제조된 후에도 그 최종생성물과 함께 남아 있게 되므로 순수한 최종 생성물을 얻기 위해서는 여러번 재결정화시켜야만 하는 공정상의 번거로움이 있었을뿐만 아니라 출발물질인 0-하이드록시아세토페논은 가격이 비싸 제조원가가 매우 높은 단점이 있었다.In general, chromone-2-carboxylic acid and especially diethylamine salt thereof are known to be useful as vascular protective agents used for venous diseases and capillary diseases. Conventionally, the compounds of formula (I) are used as starting materials. It was prepared using hydroxyacetophenone and ethyl oxalate, but when prepared according to this conventional method, since the initial reactant 0-hydroxyacetophenone remains with the final product even after the final product is prepared. In addition to the process hassles that need to be recrystallized several times to obtain a pure final product, the starting material 0-hydroxyacetophenone has a disadvantage that the manufacturing cost is very expensive.

따라서, 본 발명은 상기와 같은 종래의 문제점을 해결하기 위해 출발물질로서 저렴하고 공업상 제일의 원료라고 할 수 있는 살리실산메틸에스테르와 글리옥실산에틸에스테르를 사용하므로써 매우 저렴한 가격으로 종래에 비하여 간편한 공정에 의해 높은 수득율의 고순도 크로몬-2-카르복실산과 그 염을 제조하는 방법을 제공하는데 그 목적이 있다.Therefore, the present invention is a simple process compared to the conventional at a very low price by using a salicylic acid methyl ester and glyoxylic acid ethyl ester which is inexpensive and the industry's first raw material as a starting material to solve the above conventional problems It is an object of the present invention to provide a method for producing high purity chromone-2-carboxylic acid and its salt having high yield.

이하 본 발명의 제조방법을 상세히 설명하면 다음과 같다.Hereinafter, the manufacturing method of the present invention will be described in detail.

본 발명은 살리실산메틸에스테르와 메틸설피닐메틸나트륨을 반응시켜서 다음 구조식(II)로 표시도는 2'-하이드록시-2-메틸설피닐아세토페논을 얻은 다음, 이것을 글리옥실산에틸에스테르와 축합반응시켜서 다음 구조식(III)으로 표시되는 2-에톡시카르보닐-3-메틸설피닐크로마논 유도체를 형성시키고, 이를 묽은 황산매체중에서 가열하여 가수분해시킨후 메틸설펜산 1분자를 제거시켜서 높은 수득율로 고순도의 상기 구조식(I)의 크로몬-2-카르복실산과 그 염을 제조하는 방법인 것이다. 이때 살리실산메틸에스테르 대신에 살리실산메틸에스테르 치환물을 출발물질로 사용하게 되면 이에 상응하는 크로몬-2-카르복실산 치환물 유도체도 제조할 수 있게 된다.The present invention reacts methyl salicylate with methylsulfinylmethylsodium to obtain 2'-hydroxy-2-methylsulfinylacetophenone represented by the following structural formula (II), and then condensation reaction with ethyloxyglyoxylic acid. To form a 2-ethoxycarbonyl-3-methylsulfinylchromanone derivative represented by the following structural formula (III), which is heated in a dilute sulfuric acid medium to hydrolyze and remove one molecule of methylsulfenoic acid at high yield. It is a method of producing the high purity chromone-2-carboxylic acid and its salt of the said structural formula (I). In this case, when the salicylic acid methyl ester substituent is used as a starting material instead of the methyl salicylate, it is also possible to prepare a corresponding chromone-2-carboxylic acid derivative derivative.

이와 같은 본 발명을 반응식으로 나타내보면 다음과 같다.The present invention as described above is represented as follows.

Figure kpo00002
Figure kpo00002

이와 같은 본 발명을 실시예에 의거 더욱 상세히 설명하면 다음과 같다.Referring to the present invention in more detail based on the embodiment as follows.

[실시예 1]Example 1

2'-하이드록시-2-메틸설피닐아세토페논의 제조Preparation of 2'-hydroxy-2-methylsulfinylacetophenone

본 반응은 질소기류의 순환장치가 구비된 반응기에서 시행하였다.The reaction was carried out in a reactor equipped with a nitrogen gas circulation system.

미네랄오일중에 용해시켜서 된 0.3몰(12.7g)의 60% 수소화나트륨 현탁액을 100ml의 디메틸설폭사이드와 300ml의 벤젠혼합물속에서 완전히 용해될때까지 약 90℃의 온도로 가열시키면서 교반시킨다.0.3 mol (12.7 g) of 60% sodium hydride suspension dissolved in mineral oil is stirred while heating to a temperature of about 90 ° C. until completely dissolved in 100 ml of dimethyl sulfoxide and 300 ml of benzene mixture.

상기 용액을 완전히 용해시킨후 여기에 0.1몰(15.2g)의 살리실산에틸에스테르를 가한 다음 가열하지 않는 상태에서 1시간동안 반응시킨다.After completely dissolving the solution, 0.1 mol (15.2 g) of salicylic acid ethyl ester was added thereto, followed by reaction for 1 hour without heating.

상기 용액을 냉각시킨 다음 여기에 1000ml의 에틸에테르를 가하고 에테르로 세척하여 걸쭉한 덩어리를 얻은후 30ml의 아세트산을 가하여 15분동안 다시 반응시키고 150ml의 증류수를 첨가하여 침전시킨다.After cooling the solution, 1000 ml of ethyl ether was added thereto, washed with ether to obtain a thick mass, and 30 ml of acetic acid was added thereto to react again for 15 minutes, and 150 ml of distilled water was added to precipitate.

이와 같이 하여 형성된 침전물은 여과시키고 물로 세척한 다음 무수에탄올로 재결정화시켜서 얻어낸 화합물의 물성을 살펴보면 다음과 같다.The precipitate thus formed is filtered, washed with water and then recrystallized with anhydrous ethanol.

융점:150℃Melting Point: 150 ℃

수득률:65%Yield: 65%

적외선스펙틀머으로 그 구조를 확인한다.Check the structure with an infrared spectrometer.

[실시예 2]Example 2

2-에톡시카르보닐-3-메틸설피닐 크로마논의 제조Preparation of 2-ethoxycarbonyl-3-methylsulfinyl chromanone

40℃ 온도의 증탕기가 장치된 반응기에 100ml의 메탄올에 용해시킨 10g(0.05몰)의 2'-하이드록시-2-메틸설피닐아세토페논 용액과 200ml의 증류수에 용해시킨 30g의 탄산칼륨(K2CO3) 용액을 혼합시켜서된 미지근한 혼합용액을 넣고 10.2g(0.1몰)의 글리옥실산에틸에스테르를 교반시키면서 첨가시킨다. 상기 용액을 40℃의 온도에서 1시간동안 교반시킨후 1/2로 희석시킨 염산으로 pH1이 될때까지 산성화시키고, 이를 냉각장치에서 하룻밤동안 냉각시키면 적색의 걸쭉한 생성물이 얻어지게 되는데 이 생성물은 증류수로 세척한다.10 g (0.05 mol) of 2'-hydroxy-2-methylsulfinylacetophenone solution dissolved in 100 ml of methanol and a 30 g potassium carbonate (K 2) dissolved in 200 ml of distilled water in a reactor equipped with a steam bath at 40 ° C. The lukewarm mixed solution obtained by mixing the CO 3 ) solution was added, and 10.2 g (0.1 mol) of glyoxylic acid ethyl ester was added with stirring. The solution was stirred for 1 hour at a temperature of 40 ° C. and acidified with dilute hydrochloric acid until pH1 and cooled overnight in a chiller to give a thick red product which was then distilled into water. Wash.

이와 같이 하여 얻어낸 생성물은 그 자체로써 실용화될 수 있다.The product obtained in this way can be put into practical use by itself.

[실시예 3]Example 3

크로몬-2-카르복실산의 제조Preparation of Chromone-2-carboxylic Acid

상기 실시예 2에 의해 얻어진 적색의 걸쭉한 상태의 2-에톡시카르보닐-3-메틸설피닐크로마논에다 50% 황산을 가하고 50~60℃ 온도의 중탕기안에서 1시간동안 가열시킨다.50% sulfuric acid is added to the red, thick 2-ethoxycarbonyl-3-methylsulfinylchromenone obtained in Example 2 and heated in a hot water bath at a temperature of 50 to 60 ° C for 1 hour.

상기 용액을 냉각시킨 다음 얼음물을 부으면 크로몬-2-카르복실산이 침전된다.After cooling the solution, poured ice water to precipitate chromone-2-carboxylic acid.

상기 화합물의 물성을 살펴보면 다음과 같다.Looking at the physical properties of the compound is as follows.

융점:255~260℃Melting Point: 255 ~ 260 ℃

수득률:80%Yield: 80%

원소분석Elemental analysis

이론치:C 63.16% H 3.16%Theoretic value: C 63.16% H 3.16%

실험치:C 63.63% H 3.28%Experimental value: C 63.63% H 3.28%

[실시예 4]Example 4

크로몬-2-카르복실산의 디에틸아민염의 제조Preparation of diethylamine salt of chromone-2-carboxylic acid

무수에탄올중에서 11.4g(0.06몰)의 크로몬-2-카르복실산과 4.4g의 디에틸아민을 1시간동안 환류하에 가열시킨 다음 냉각시키면 염이 침전된다. 이것을 무수알코올과 아세톤의 혼합물중에서 재결정시키면 수용성 백색분말이 얻어지게 된다.In anhydrous ethanol, 11.4 g (0.06 mole) of chromone-2-carboxylic acid and 4.4 g of diethylamine are heated under reflux for 1 hour and then cooled to precipitate salts. This is recrystallized in a mixture of anhydrous alcohol and acetone to obtain a water-soluble white powder.

융점:139℃Melting Point: 139 ℃

수득률:90%Yield: 90%

[실시예 5]Example 5

크로몬-2-카르복실산의 리신염의 제조Preparation of Lysine Salt of Chromon-2-carboxylic Acid

100ml의 에탄올중에서 9.5g(0.05몰)의 크로몬산을 60℃의 온도까지 가열하고 거기에다 10ml의 증류에 용해된 14.6g의 50% 리신을 첨가시켜 완전히 용해시킨다. 그 다음으로 여기에다 100ml의 아세톤을 가하고, -5℃의 온도에서 하룻밤동안 냉각시킨후, 여과건조시키면 담황색분말의 크로몬-2-카르복실산의 리신염 14.8g이 얻어진다.In 100 ml of ethanol, 9.5 g (0.05 mole) of chromonic acid is heated to a temperature of 60 ° C. and dissolved in it by adding 14.6 g of 50% lysine dissolved in 10 ml of distillation. Next, 100 ml of acetone was added thereto, cooled overnight at a temperature of −5 ° C., and then filtered and dried to obtain 14.8 g of a lysine salt of chromone-2-carboxylic acid as pale yellow powder.

수득률:88%Yield: 88%

[실시예 6]Example 6

크로몬-2-카르복실산의 마그네슘염의 제조Preparation of Magnesium Salt of Chromon-2-carboxylic Acid

100ml의 증류수와 10ml의 95% 에탄올의 혼합물에다 19g(0.1몰)의 크로몬-2-카르복실산을 용해시켜서 된 현탁액내에 50ml의 증류수에 5g의 수산화탄산마그네슘을 용해시켜서 된 용액을 첨가시킨다.A solution obtained by dissolving 5 g of magnesium hydroxide in 50 ml of distilled water is added to a suspension of 19 g (0.1 mole) of chromone-2-carboxylic acid in a mixture of 100 ml of distilled water and 10 ml of 95% ethanol.

이 용액을 하룻밤동안 냉각시킨후 45℃의 온도조건하에 진공상태에서 농축시켜서 이때 얻어지는 생성물을 무수에탄올로 재결정시키고 메틸에틸케톤으로 세척한다.The solution was cooled overnight and then concentrated in vacuo under a temperature condition of 45 DEG C. The resulting product was recrystallized from anhydrous ethanol and washed with methyl ethyl ketone.

이때 수득률은 90%이고 이 생성물을 다시 2몰의 H2O로 결정화시킨다.The yield is then 90% and the product is crystallized again with 2 moles of H 2 O.

본 발명은 상술한 실시예에 한정되는 것이 아니라 다른 변형예로도 실시 가능하다.The present invention is not limited to the above-described embodiment but can be implemented in other modifications.

Claims (6)

디메틸설폭사이드와 수소화나트륨의 혼합물내에 존재하는 메틸설피닐메틸나트륨을 살리실산메틸에스테르와 반응시켜서 2'-하이드록시-2-메틸설피닐아세토페논을 형성시키고, 이렇게 형성된 화합물을 글리옥실산에틸에스테르와 축합반응시켜 2-에톡시카르보닐-3-메틸설피닐크로마논 유도체를 형성시킨 다음 산가수분해시켜서 되는 다음 구조식(I)로 표시되는 크로몬-2-카르복실산과 그 염을 제조하는 방법.The methylsulfinylmethylsodium present in the mixture of dimethyl sulfoxide and sodium hydride is reacted with methyl salicylate to form 2'-hydroxy-2-methylsulfinylacetophenone, and the compound thus formed is combined with ethyl glyoxylate A condensation reaction to form 2-ethoxycarbonyl-3-methylsulfinylchromanone derivative, followed by acid hydrolysis, to prepare chromone-2-carboxylic acid represented by the following structural formula (I) and a salt thereof.
Figure kpo00003
Figure kpo00003
상기 식중 R은 수소나 염소, 메톡시기, 메틸기 또는 하이드록시기를 나타내며, M+는 칼슘이나 마그네슘 같은 양이온, B+는 디에틸아민 또는 모르포린 같은 유기염기나 아르기닌 또는 리신 같은 염기성 아미노산 중에서 선택된 염기성양이온을 나타낸다.Wherein R represents hydrogen or chlorine, methoxy, methyl or hydroxy group, M + is a cation such as calcium or magnesium, B + is a basic cation selected from organic bases such as diethylamine or morpholine or basic amino acids such as arginine or lysine Indicates.
제1항에 있어서, 살리실산메틸에스테르와 메틸설피닐메틸나트륨의 반응은 40℃의 온도로 증류수 중에서 시행되어지는 방법.The method according to claim 1, wherein the reaction of methyl salicylate and methylsulfinylmethylsodium is carried out in distilled water at a temperature of 40 ° C. 제1항에 있어서, 산가수분해는 가열상태하에서 1/2로 희석시킨 황산으로 처리하여서 이루어지도록 하는 방법.The method according to claim 1, wherein the acid hydrolysis is performed by treatment with sulfuric acid diluted in half under heating. 제1항에 있어서, 크로몬-2-카르복실산은 무수에탄올중에서 디에틸아민과 반응시켜서 이에 상응하는 크로몬-2-카르복실산염이 되어지도록하는 방법.The process of claim 1 wherein the chromone-2-carboxylic acid is reacted with diethylamine in anhydrous ethanol to result in the corresponding chromone-2-carboxylate. 제1항에 있어서, 크로몬-2-카르복실산은 무수에탄올중에서 50% 리신수용액과 반응시켜서 이에 상응하는 크로몬-2-카르복실산의 염이 되어지도록 하는 방법.The process of claim 1 wherein the chromone-2-carboxylic acid is reacted with 50% lysine aqueous solution in anhydrous ethanol to become the corresponding salt of chromone-2-carboxylic acid. 제1항에 있어서, 크로몬-2-카르복실산은 미지근한 알코올수용액중에서 수산화탄산마그네슘과 반응시키고, 무수에탄올로 재결정시켜서 이에 상응하는 크로몬-2-카르복실산의 염이 되어지도록 하는 방법.The method of claim 1, wherein the chromone-2-carboxylic acid is reacted with magnesium hydroxide in lukewarm aqueous alcohol solution and recrystallized with anhydrous ethanol to become the corresponding salt of chromone-2-carboxylic acid.
KR1019830000202A 1983-01-20 1983-01-20 Process for preparing chromore-2-carboxylic acid and salts thereof KR860000845B1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
KR1019830000202A KR860000845B1 (en) 1983-01-20 1983-01-20 Process for preparing chromore-2-carboxylic acid and salts thereof

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
KR1019830000202A KR860000845B1 (en) 1983-01-20 1983-01-20 Process for preparing chromore-2-carboxylic acid and salts thereof

Publications (2)

Publication Number Publication Date
KR840003249A KR840003249A (en) 1984-08-20
KR860000845B1 true KR860000845B1 (en) 1986-07-09

Family

ID=19228055

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1019830000202A KR860000845B1 (en) 1983-01-20 1983-01-20 Process for preparing chromore-2-carboxylic acid and salts thereof

Country Status (1)

Country Link
KR (1) KR860000845B1 (en)

Also Published As

Publication number Publication date
KR840003249A (en) 1984-08-20

Similar Documents

Publication Publication Date Title
US3484445A (en) Derivatives of chromone-2-carboxylic acid
US4808728A (en) Production of indolepyruvic acid and the 5-hydroxy derivative thereof
IL45113A (en) 6-substituted-2-benzoxyzolinone derivatives and their preparation
KR860000845B1 (en) Process for preparing chromore-2-carboxylic acid and salts thereof
US3585214A (en) Hydroxyl derivatives of coumarine and processes for the preparation thereof
US3607884A (en) Preparation of 5-carboxyphthalide in liquid sodium trioxide
EP0390496B1 (en) Intermediates useful for the synthesis of delphinidin chloride
US4264773A (en) Preparation of 2-chloro-thioxanthone
HU176293B (en) Process for preparing salicylic acid derivatives
Kleinspehn et al. A Proof of Structure for 2-Bromo-3-methyl-4-carbethoxypyrrole1
JPH09268186A (en) Production of 4-chromanones
US4298530A (en) Process for production of 3-hydroxy-3-methylphthalide or the nuclearly substituted derivatives thereof
Breslow et al. Condensations brought about by bases. V. The condensation of the anhydride with the aldehyde in the Perkin synthesis
Schock Jr et al. The Persulfate Oxidation of Salicylic Acid. 2, 3, 5-Trihydroxybenzoic Acid
Cason A convenient method for the preparation of hydroxy naphthoic acids
US4227016A (en) Process for manufacturing α-chloroarylacetic acids
US4691062A (en) Process for the production of 4-chloro-butanals
JP4018162B2 (en) Method for producing hydroxyphenylacetic acid
JPH0481576B2 (en)
KR920001768B1 (en) Process for preparing cromone carboxylate
JP3563424B2 (en) Method for producing 4H-pyran-4-one
JPS63188647A (en) Production of bis(3-tert-butyl-4-hydroxyphenyl)acetic acids
US3524878A (en) 2,6-(alpha,alpha-dibromomethyl)benzoic acid derivatives
KR950005767B1 (en) Preparation of methyl-3,4-dihydroxy-5-methoxy benzoate
KR100503267B1 (en) Method for the preparation of 2-acetyloxy-4-trifluoromethyl benzoic acid

Legal Events

Date Code Title Description
A201 Request for examination
E902 Notification of reason for refusal
G160 Decision to publish patent application
E701 Decision to grant or registration of patent right
GRNT Written decision to grant
FPAY Annual fee payment

Payment date: 20010710

Year of fee payment: 16

LAPS Lapse due to unpaid annual fee